The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

The medicines regulator is investigating after hundreds of people have reported problems with their pancreas linked to taking ...

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...

UK health officials have launched a study into side-effects of weight loss drugs including Ozempic, Mounjaro and Wegovy ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

The UK’s drug regulator is to study possible serious side effects of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro). Data from ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

Pancreatitis cases are increasing in India, especially among young adults. Experts link it to alcohol use, gallstones, ...